Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05490225 · ClinicalTrials.gov registry record · NA
Access Cannulation Trial II
A NA study of Vascular Access Complication and Dialysis; Complications, sponsored by Voyager Biomedical.
- Recruiting
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 8
- Study locations
NCT05490225 is a NA study of Vascular Access Complication and Dialysis; Complications that is actively recruiting participants, run by Voyager Biomedical. The registered enrollment target is 100 participants, below the 739-participant average among 6 other Vascular Access Complication trials with a reported enrollment target (86% lower). The trial reports 8 study locations across 7 states.
The verdict
NCT05490225, a NA study of Vascular Access Complication and Dialysis; Complications, is actively recruiting participants, sponsored by Voyager Biomedical.
- RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 8
- Study locations
Study Summary
This is a pivotal, interventional, prospective, single-arm, open-label, multi-site clinical investigation intended to support FDA clearance of the study device based on the safety and efficacy of the device in cannulating arteriovenous fistulas (AVFs) for hemodialysis procedures.
Conditions Studied
Interventions
- DEVICE VenaSure
Study Locations (8)
Texas
- Cardiothoracic and Vascular Surgeons - Austin
- Baylor Scott & White - Dallas
Alabama
- Trinity Research Group - Dothan
California
- Apex Research - Riverside
Massachusetts
- Brigham and Women's Hospital - Boston
New York
- Northwell Health - Hyde Park
South Carolina
- MUSC Health Orangeburg - Orangeburg
Virginia
- Fairlawn Surgery Center - Roanoke
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2025-04-23 |
| Est. Completion | 2027-03-25 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05490225
The ClinicalTrials.gov registry entry for NCT05490225 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 739-participant average among 6 other Vascular Access Complication trials with a reported enrollment target (86% lower). The listed sponsor is Voyager Biomedical, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Vascular Access Complication appearing as the primary indexed condition, and to 1 intervention - of which VenaSure is the first listed.
NCT05490225 reports 8 study locations spanning 7 distinct geographic areas - top geographies include Texas, Alabama, California.
Frequently Asked Questions
What is clinical trial NCT05490225 about?
NCT05490225 is a clinical study titled "Access Cannulation Trial II". This is a pivotal, interventional, prospective, single-arm, open-label, multi-site clinical investigation intended to support FDA clearance of the study device based on the safety and efficacy of the device in cannulating arteriovenous fistulas (AVFs) for hemodialysis procedures.
What is the current status of trial NCT05490225?
This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2025-04-23. Estimated completion is 2027-03-25.
What conditions does trial NCT05490225 study?
This clinical trial studies the following conditions: Vascular Access Complication, Dialysis; Complications.
What interventions are being tested in trial NCT05490225?
The interventions under investigation include: VenaSure (DEVICE).
Who is sponsoring clinical trial NCT05490225?
This trial is sponsored by Voyager Biomedical, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05490225 being conducted?
This trial has 8 study locations across Alabama, California, Massachusetts, New York, South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Vascular Access Complication
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study
RECRUITING · NA
-
Radial Vs. State-Of-The-Art Femoral Access for Bleeding and Access Site Complication Reduction in Cardiac Catheterization (REBIRTH)
RECRUITING · NA
-
Dual-plane Ultrasound Imaging During Vascular Access Procedures
COMPLETED · NA
-
Autologous Adipose Derived Mesenchymal Stem Cells (AMSC) in Reducing Hemodialysis Arteriovenous Fistula Failure
ACTIVE NOT RECRUITING · Phase 1
-
RADIAL Versus Femoral Access for Coronary Artery Bypass Graft Angiography and Intervention (RADIAL-CABG) Trial
COMPLETED · Phase 3
-
Trial to Evaluate the Sirolimus-Eluting Collagen Implant on AV Fistula Outcomes
COMPLETED · Phase 3
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.